Related Experiment Video
Updated: Jan 16, 2026

Fluorescence-mediated Tomography for the Detection and Quantification of Macrophage-related Murine Intestinal Inflammation
Published on: December 15, 2017
Macrophages: emerging targets for ulcerative colitis.
Siqing Chen1, Zhang Qin2, Xiaoyuan Lin1
1Department of Gastroenterology, The First Hospital of Hunan University of Chinese Medicine, Changsha, Hunan, China.
Macrophage dysfunction drives ulcerative colitis (UC) pathogenesis. Targeting macrophage pathways, including metabolic reprogramming, offers promising therapeutic strategies for this chronic inflammatory bowel disease.
Area of Science:
- Immunology
- Gastroenterology
- Cell Biology
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) with complex causes and few treatments.
- Macrophages are crucial in UC, influencing inflammation and tissue repair.
- A comprehensive summary of macrophage regulatory pathways in UC is lacking.
Purpose of the Study:
- To systematically review the role of macrophages in UC.
- To elucidate macrophage regulatory mechanisms in UC.
- To identify potential therapeutic strategies and future research directions for UC.
Main Methods:
- Conducted a comprehensive literature review.
- Integrated global studies on macrophage pathways in UC.
- Focused on molecular mechanisms of macrophage polarization and function.
Main Results:
- Macrophage dysfunction is central to UC pathogenesis.
- Metabolic reprogramming fundamentally alters macrophage phenotype and function.
- Epigenetic modifications, chemokine recruitment, microbial metabolites, autophagy, and apoptosis also mediate macrophage changes.
Conclusions:
- Targeting macrophage pathways is an effective therapeutic strategy for UC.
- This review provides a foundation for precision treatments modulating macrophages.
- Identified new avenues for future research in UC and macrophage biology.
Related Concept Videos
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammation

